Agnirva Space Premier League - Expedition #30399: Hunting Parkinson’s Clues in Space: Crystallizing LRRK2 in Microgravity

Parkinson’s disease affects millions worldwide, and one protein—LRRK2—has emerged as a crucial player in this condition. By understanding LRRK2’s structure, scientists can potentially unlock new ways to treat or even prevent Parkinson’s. But there’s a problem: growing quality crystals of LRRK2 on Earth is extremely difficult.

The 'Crystallization of LRRK2 Under Microgravity Conditions-2' experiment tackled this challenge head-on by sending the protein to the ISS. The goal was to grow better-ordered crystals of LRRK2 in microgravity, where the absence of convection and sedimentation creates an ideal environment for uniform crystal growth.

Led by researchers from The Michael J. Fox Foundation and top academic institutions, the project hoped to generate crystals suitable for high-resolution X-ray crystallography. These detailed structures would allow scientists to see how LRRK2 functions—and malfunctions—at the atomic level.

If successful, these insights could pave the way for targeted therapies that inhibit the harmful actions of LRRK2, offering hope to patients and families affected by Parkinson’s.

This experiment is a perfect example of how the ISS supports biomedical research, using space to overcome Earth-bound limitations in the fight against disease.

Get certified with over 100 hours of immersive, self-paced learning in astronomy, cosmology, space technology, and climate science through the Agnirva Space Internship Program. Join, complete virtual projects, and earn a digital certificate to showcase your space fluency in interviews, resumes, and beyond.